Literature DB >> 9694051

Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD.

M G Danieli1, P Fraticelli, A Salvi, A Gabrielli, G Danieli.   

Abstract

Connective tissue diseases (CTDs) are chronic multisystemic inflammatory disorders whose indicative signs or symptoms have a high sensitivity but poor specificity in predicting the evolution into a given CTD. We have analysed 84 consecutive patients initially diagnosed as having an early undifferentiated CTD (early UCTD) with the aim of verifying the evolution into one definite CTD and of evaluating the predictive value of clinical and laboratory parameters. During a 5-year study period, 33 patients developed signs of a full-blown CTD; the highest probability of evolution was in the first 48 months after the onset. Multivariate analysis allowed us to select those variables correlating with evolution into a particular CTD, such as sclerodactyly and oesophageal dysfunction for systemic sclerosis, xerostomia and anti-nuclear antibodies (SS-A pattern) for Sjögren's syndrome, and fever and anti-DNA antibodies for systemic lupus erythematosus. Furthermore, we assessed the prevalence of various clinical and laboratory manifestations, complications and prognosis of those patients diagnosed after a 5-year disease duration period as having a UCTD. In our series, major organs such as the kidney or heart seem to be spared, whereas we detected a relatively high prevalence of endocrine disease of autoimmune origin.

Entities:  

Mesh:

Year:  1998        PMID: 9694051     DOI: 10.1007/bf01451046

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Neoplastic lymphoproliferation in autoimmune disease: an updated review.

Authors:  V Santana; N R Rose
Journal:  Clin Immunol Immunopathol       Date:  1992-06

3.  Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.

Authors:  D D Gerbracht; V D Steen; G L Ziegler; T A Medsger; G P Rodnan
Journal:  Arthritis Rheum       Date:  1985-01

Review 4.  Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions.

Authors:  C G Kallenberg
Journal:  Curr Opin Rheumatol       Date:  1995-11       Impact factor: 5.006

5.  Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.

Authors:  C G Kallenberg; A A Wouda; M H Hoet; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

6.  The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon.

Authors:  H Wollersheim; T Thien; M H Hoet; W J Van Venrooy
Journal:  Eur J Clin Invest       Date:  1989-12       Impact factor: 4.686

7.  Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.

Authors:  D Alarcón-Segovia; M H Cardiel
Journal:  J Rheumatol       Date:  1989-03       Impact factor: 4.666

8.  Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.

Authors:  I Lundberg; E Hedfors
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

9.  Raynaud's phenomenon together with antinuclear antibodies: a common subset of incomplete connective tissue disease.

Authors:  M Vayssairat; N Baudot; J P Gaitz
Journal:  J Am Acad Dermatol       Date:  1995-05       Impact factor: 11.527

10.  "Latent lupus".

Authors:  L Ganczarczyk; M B Urowitz; D D Gladman
Journal:  J Rheumatol       Date:  1989-04       Impact factor: 4.666

View more
  19 in total

1.  Development of SLE among "potential SLE" patients seen in consultation: long-term follow-up.

Authors:  M Al Daabil; E M Massarotti; A Fine; H Tsao; P Ho; P H Schur; B L Bermas; K H Costenbader
Journal:  Int J Clin Pract       Date:  2014-05-23       Impact factor: 2.503

Review 2.  Preclinical systemic lupus erythematosus.

Authors:  Julie M Robertson; Judith A James
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

3.  We need better classification and terminology for "people at high risk of or in the process of developing lupus".

Authors:  Karen H Costenbader; Peter H Schur
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

4.  Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010.

Authors:  P Elfving; O Marjoniemi; H Niinisalo; A Kononoff; L Arstila; E Savolainen; J Rutanen; O Kaipiainen-Seppänen
Journal:  Rheumatol Int       Date:  2016-04-06       Impact factor: 2.631

5.  Screening characteristics for enrichment of individuals at higher risk for transitioning to classified SLE.

Authors:  K A Young; M E Munroe; J M Guthridge; D L Kamen; G S Gilkensen; J B Harley; M H Weisman; D R Karp; D J Wallace; J A James; J M Norris
Journal:  Lupus       Date:  2019-03-07       Impact factor: 2.911

6.  Undifferentiated connective tissue disease in a rheumatology center in Cali, Colombia: clinical features of 94 patients followed for a year.

Authors:  Luis F Guerrero; Juan C Rueda; Raquel Arciniegas; Jorge M Rueda
Journal:  Rheumatol Int       Date:  2011-11-25       Impact factor: 2.631

Review 7.  Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: case report and review of literature.

Authors:  Francesca Lunardi; Elisabetta Balestro; Beatrice Nordio; Franco Cozzi; Roberta Polverosi; Paolo Sfriso; Fausto Braccioni; Fiorella Calabrese
Journal:  Diagn Pathol       Date:  2011-06-07       Impact factor: 2.644

8.  Raynaud's phenomenon in undifferentiated connective tissue disease (UCTD).

Authors:  Rossella De Angelis; Angela Cerioni; Patrizia Del Medico; Patrizia Blasetti
Journal:  Clin Rheumatol       Date:  2004-09-04       Impact factor: 2.980

9.  Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients.

Authors:  C C Vaz; M Couto; D Medeiros; L Miranda; J Costa; P Nero; R Barros; M J Santos; E Sousa; A Barcelos; L Inês
Journal:  Clin Rheumatol       Date:  2009-04-24       Impact factor: 2.980

10.  Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function.

Authors:  Brent W Kinder; Cyrus Shariat; Harold R Collard; Laura L Koth; Paul J Wolters; Jeffrey A Golden; Ralph J Panos; Talmadge E King
Journal:  Lung       Date:  2010-04       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.